EyePoint (EYPT) EBT Growth (5y) (2015 - 2026)
EyePoint (EYPT) EBT Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,719.23 Bn | 65,718.94 Bn | - |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 471.85 Bn | 467.06 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.29 Bn | 115.04 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.04 Bn | 61.28 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.06 Bn | 62.06 Bn | - |
| 8 | Argenx Se | 55.78 Bn | 50.60 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.47 Bn | 34.47 Bn | 959.66 Mn |
| 10 | EyePoint | 1.07 Mn | -221.48 Mn | 168,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -57.82% |
| Dec 31, 2025 | -33.19% |
| Sep 30, 2025 | -73.52% |
| Jun 30, 2025 | -35.57% |
| Mar 31, 2025 | -31.70% |
| Dec 31, 2024 | -23.18% |
| Sep 30, 2024 | -13.15% |
| Jun 30, 2024 | -21.25% |
| Mar 31, 2024 | -44.15% |
| Dec 31, 2023 | 9.02% |
| Sep 30, 2023 | 3.42% |
| Jun 30, 2023 | -19.36% |
| Mar 31, 2023 | -36.44% |
| Dec 31, 2022 | -50.17% |
| Sep 30, 2022 | -71.94% |
| Jun 30, 2022 | -58.56% |
| Mar 31, 2022 | -30.60% |
| Dec 31, 2021 | -212.36% |
| Sep 30, 2021 | -18.45% |
| Jun 30, 2021 | -22.37% |